Intricon FCF/Debt
Delisted
Free Cash Flow to Debt Ratio of Intricon (IIN) as of Sep 10, 2026.
Get this data via API
Financial Data API
FCF/Debt
0.00
Last updated:
Free Cash Flow to Debt Ratio of Intricon is 2026 0.00 . Free Cash Flow to Debt Ratio of Intricon was 2025 0.00 . It decreases by % lower compared to the previous year.
The Intricon FCF/Debt history
3 Years
10 Years
25 Years
Max
FCF/Debt
Date
FCF/Debt
Jan 1, 2014
19.96 USD
Jan 1, 2015
-35.39 USD
Jan 1, 2016
-18.72 USD
Jan 1, 2017
16.82 USD
Jan 1, 2019
-3,123.00 USD
| YEAR | FCF/Debt | YoY |
|---|---|---|
| -3,123.00 % | -18,671.83% | |
| 16.82 % | -189.85% | |
| -18.72 % | -47.11% | |
| -35.39 % | -277.32% | |
| 19.96 % | — |
Access this data via the Eulerpool API
Intricon Stock analysis
What does Intricon do? IntriCon Corp is a leading global provider of microelectronic components and solutions for various industries such as medical, energy, audio, communication, and security. The company was founded in 1930 as Intricate Assemblies and is headquartered in Arden Hills, Minnesota, USA. IntriCon has been listed on the NASDAQ stock exchange since 1967.
IntriCon is known for its innovative solutions that enable customers to improve the performance and efficiency of their products. The company has extensive manufacturing capabilities in various parts of the world, including the USA, Singapore, Indonesia, and China.
IntriCon's business model is based on a custom product range tailored to the specific requirements of industries. IntriCon specializes in developing custom solutions for complex technological problems. The company heavily invests in research and development to find innovative solutions for customers. IntriCon works closely with its customers to ensure that the solutions meet the requirements.
IntriCon Corp offers its services in two main business areas: Medical/Healthcare and Hearing Health. In the Medical/Healthcare sector, the company specializes in the development and manufacturing of microelectronic components for medical applications. IntriCon offers its customers a wide range of products, including wireless communication and monitoring systems for patients, hearing aids, implantable medical devices, and high-precision sensors for medical instruments.
In the Hearing Health sector, IntriCon specializes in the development and manufacturing of hearing aids and wireless communication systems. IntriCon develops innovative hearing aid technologies that allow customers to achieve higher sound quality and better amplification options. The company also offers wireless communication systems that enable customers to communicate wirelessly with other devices.
IntriCon Corp is known for its ability to develop custom solutions for complex technological problems. The company is able to quickly adapt production capacity to respond to changing market demands. The company is also committed to continuously improving the quality of its products to ensure they meet the requirements of its customers.
In addition to its main business areas, IntriCon also offers engineering services focused on developing custom solutions. The company leverages its extensive technical expertise to assist customers in developing innovative products, systems, and components.
Overall, IntriCon Corp is a leading provider of microelectronic components and solutions for various industries. The company specializes in custom solutions and has extensive manufacturing capabilities in various parts of the world. IntriCon heavily invests in research and development to find innovative solutions for customers. IntriCon is known for its ability to develop custom solutions for complex technological problems and is committed to continuously improving the quality of its products. Intricon is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Intricon stock
On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Intricon since 2006 – with annual values, charts, and detailed analysis.
FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.
A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Intricon with sector peers and the industry average to assess whether it is attractive.
Access this data via the Eulerpool API
Leverage — Intricon
All Key Metrics — Intricon
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth